Which factors impact myocardial function in systemic sclerosis?

Echocardiography

Volumn 29, Issue 3, 2012, Pages 307-317

  Ivanovic, Branislava A ^a,b   Tadic, Marijana V ^b   Zlatanovic, Maja M ^c   Damjanov, Nemanja N ^a,c   Ostojiä, Predrag M ^c   Bonaci Nikolic, Branka N ^a,b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

^c Institute for Rheumatology   (Serbia)

Author keywords

left ventricle; myocardial function; right ventricle; systemic sclerosis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CARBON MONOXIDE;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICULAR DIASTOLIC FUNCTION; HEART RIGHT VENTRICLE FUNCTION; HEART RIGHT VENTRICULAR DIASTOLIC FUNCTION; HUMAN; LEFT VENTRICULAR GLOBAL FUNCTION; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; LUNG VASCULAR RESISTANCE; MITRAL VALVE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RIGHT VENTRICULAR GLOBAL FUNCTION; SEROLOGY; SYSTEMIC SCLEROSIS; SYSTOLIC BLOOD PRESSURE; TEI INDEX; TISSUE DOPPLER IMAGING; TRICUSPID VALVE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

COMORBIDITY; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SCLERODERMA, SYSTEMIC; SENSITIVITY AND SPECIFICITY; SERBIA; VENTRICULAR DYSFUNCTION;

EID: 84858794231     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2011.01560.x     Document Type: Article

References (32)

1. Kahan A, Allanore Y,: Primary myocardial involvement in systemic sclerosis. Rheumatology (Oxford) 2006; 45 (Suppl. 4): 14-17.
2. Fernandes F, Ramires FJ, Arteaga E, et al,: Cardiac remodeling in patients with systemic sclerosis with no signs or symptoms of heart failure: An endomyocardial biopsy study. J Card Fail 2003; 9 (4): 311-317.
3. D'Andrea A, Stisi S, Bellissimo S, et al,: Early impairment of myocardial function in systemic sclerosis: Non-invasive assessment by Doppler myocardial and strain rate imaging. Eur J Echocardiogr 2005; 6 (6): 407-418.
4. Meune C, Avouac J, Wahbi K, et al,: Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: A controlled study of 100 consecutive patients. Arthritis Rheum 2008; 58 (6): 1803-1809.
5. Schattke S, Knebel F, Grohmann A, et al,: Early right ventricular systolic dysfunction in patients with systemic sclerosis without pulmonary hypertension: A Doppler Tissue and Speckle Tracking echocardiography study. Cardiovasc Ultrasound 2010; 22 (8): 3-11.
6. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-590.
7. LeRoy EC, Black C, Fleischmajer R, et al,: Scleroderma (systemic sclerosis): Classification, subset and pathogenesis. J Rheumatol 1988; 15: 202-205.
8. Schiller NB, Shah PM, Crawford M, et al,: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-367.
9. Devereux RB, Reichek N,: Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613-618.
10. de Simone G, Devereux RB, Daniels SR, et al,: Effect of growth on variability of left ventricular mass; assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 1995; 25: 1056-1062.
11. Quinones MA, Otto CM, Stoddard M, et al,: Recommendations for quantification of Doppler echocardiography: A report from the Doppler quantification task force of the nomenclature and standards committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002; 15: 167-184.
12. Tei C, Ling LH, Hodge DO, et al,: New index of combined systolic and diastolic myocardial performance: A simple and reproducible measure of cardiac function-a study in normals and dilated cardiomyopathy. J Cardiol 1995; 26: 357-366.
13. Rudski LG, Lai WW, Afilalo J, et al,: Guidelines for the echocardiographic assessment of the right heart in adults: A report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010; 23 (7): 685-713.
14. Kouzu H, Nakatani S, Kyotani S, et al,: Noninvasive estimation of pulmonary vascular resistance by Doppler echocardiography in patients with pulmonary arterial hypertension. Am J Cardiol 2009; 103 (6): 872-876.
15. Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, et al,: Mortality in systemic sclerosis: An international meta-analysis of individual patient data. Am J Med 2005; 118: 2-10.
16. Maione S, Cuomo G, Giunta A, et al,: Echocardiographic alterations in systemic sclerosis: A longitudinal study. Semin Arthritis Rheum 2005; 34 (5): 721-727.
17. Lindqvist P, Caidahl K, Neuman-Andersen G, et al,: Disturbed right ventricular diastolic function in patients with systemic sclerosis: A Doppler tissue imaging study. Chest 2005; 128 (2): 755-763.
18. Vonk MC, Sander MH, van den Hoogen FH, et al,: Right ventricle Tei-index: A tool to increase the accuracy of non-invasive detection of pulmonary arterial hypertension in connective tissue diseases. Eur J Echocardiogr 2007; 8 (5): 317-321.
19. de Groote P, Gressin V, Hachulla E, et al,; ItinerAIR-Scleroderma Investigators: Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis. Ann Rheum Dis 2008; 67 (1): 31-36.
20. Poanta L, Dadu R, Tiboc C, et al,: Systolic and diastolic function in patients with systemic sclerosis. Eur J Intern Med 2009; 20 (4): 378-382.
21. Emdin M, Marini C, Passino C, et al,: Right ventricular overload and cardiovascular neuroendocrine derangement in systemic sclerosis. Eur Heart J Suppl 2004; 6: F68-F73.
22. Mathai SC, Bueso M, Hummers LK, et al,: Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension. Eur Respir J 2010; 35 (1): 95-104.
23. Nagaya N, Nishikimi T, Uematsu M, et al,: Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 2000; 102: 865-870.
24. Williams MH, Handler CE, Akram R, et al,: Role of N-terminal brain natriuretic peptide (NT-proBNP) in scleroderma-associated pulmonary arterial hypertension. Eur Heart J 2006; 27: 1485-1494.
25. Dimitroulas T, Giannakoulas G, Papadopoulou K, et al,: Early detection of cardiac involvement in systemic sclerosis assessed by tissue-Doppler echocardiography: Relationship with neurohormonal activation and endothelial dysfunction. J Rheumatol 2010; 37 (5): 993-999.
26. Giannoni A, Tani C, Clerico A, et al,: When the heart is burning: Amino-terminal pro-brain natriuretic peptide as an early marker of cardiac involvement in active autoimmune rheumatic disease. Int J Cardiol 2011; 148 (2): 161-167.
27. Cavagna L, Caporali R, Klersy C, et al,: Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis. J Rheumatol 2010; 37 (10): 2064-2070.
28. Bulkley BH, Ridolfi RL, Salyer WR, et al,: Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction. Circulation 1976; 53: 483-490.
29. James TN,: De subitaneis mortibus. VIII. Coronary arteries and conduction system in scleroderma heart disease. Circulation 1974; 50: 844-856.
30. D'Andrea A, Stisi S, Caso P, et al,: Associations between left ventricular myocardial involvement and endothelial dysfunction in systemic sclerosis: Noninvasive assessment in asymptomatic patients. Echocardiography 2007; 24 (6): 587-597.
31. Ferri C, Emdin M, Giuggioli D, et al,: Autonomic dysfunction in systemic sclerosis: Time and frequency domain 24 hour heart rate variability analysis. Br J Rheumatol 1997; 36: 669-676.
32. Denton CP, Cailes JB, Phillips GD, et al,: Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. Br J Rheumatol 1997; 36 (2): 239-243.